Solana Co — Director's Dealing 2018

Apr 17, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2018-04-13

Reporting Person: GRIFFIN THOMAS E (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-04-13	Class A Common Stock	P	3346	$7.47	Acquired	3346	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-04-13	Warrant (Right to Buy)	$12.25	P	3346	Acquired	2021-04-10	Class A Common Stock (3346)	Direct

Footnotes

F1: The Class A Common Stock and the Warrant to Purchase Class A Common Stock was purchased by the Reporting Person in a private placement as a Unit. The purchase price of the Unit was $7.47.

F2: The strike price of the Warrant is CAD$12.25.

F3: Immediately exercisable.